Ex­clu­sive: Top lob­by­ist at BIO leaves as trade group grap­ples with US-Chi­na ten­sions

Nick Ship­ley, the chief ad­vo­ca­cy of­fi­cer at the Biotech­nol­o­gy In­no­va­tion Or­ga­ni­za­tion (BIO), has left the trade group, End­points News has learned.

Ship­ley played a key role in Wash­ing­ton lob­by­ing on the biotech in­dus­try’s be­half, in­clud­ing a bill that would bar some Chi­nese life sci­ence com­pa­nies from do­ing busi­ness with US biotechs.

BIO and Ship­ley con­firmed his de­par­ture to End­points, and as of Wednes­day, his pho­to and de­tails were no longer list­ed on BIO’s web­site.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER